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Topical application of 400 11-g of cantharidin to the rat's ear caused an approximate 
doubling in the mean weight of uniform ear punch samples when compared to vehicle-
treated controls at 72 hr, and produced a maximal response at 7 days. Dexamethasone 
reduced the increase in weight when applied topically, but was ineffective when given 
subcutaneously or orally at the same doses. 
Hydrocortisone, prednisolone, triamcinolone, betamethasone, flurometholone, parameth-
asone acetate, fluocinolone acetonide, fluocinonide , and flurandrenolide showed significant 
suppression of cantharidin-induced inflammation. Cholesterol, diphenhydramine, tripelen-
namine, chlorpheniramine, promethazine, cyproheptadine, epinephrine, phenylephrine, 
alpha-tocopherol, indomethacin, and bufexamac were inactive. It is suggested that the 
procedure employed may be useful in the screening and evaluation of topical anti-inflamma-
tory agents. 
Various procedures are available for the assess-
ment of topical anti-inflammatory activity in man. 
These techniques, developed for investigation of 
the topical effectiveness of corticosteroids, include 
methods based upon inhibition of inflammation 
induced with various cht!mical irritants such as 
mustard oil and nitric acid l l ], croton oil [2], and 
tetrahydrofurfuryl alcohol [3[. Other procedures 
take advantage of the blanching or vasoconstrictor 
property of topically applied corticosteroids l4J. 
since tests of various corticosteroids have shown 
good correlation between vasoconstrictor potency 
and topical effectiveness clinically in inflamma-
tory skin conditions [5-7]. 
Animal models suitable for finding and evaluat-
ing topically active, anti-inflammatory compounds 
a re not nearly as numerous as their clinical coun-
terparts. Several animal methods are based on the 
"' local" effect of compounds applied to cotton pellets 
implanted subcutaneously 18], or injected directly 
into granuloma pouches induced with croton oil 
[9,10]. It is questionable whether such "local" ef-
fects mimic topical activity and are predictive of 
dermatologic effectiveness. 
A direct approach to the determination of topical 
anti-inflammatory activity in an animal model is 
the method developed by Tonelli and his associates 
lll). This procedure is based on the inhibition of 
rat ear inflammation induced with croton oil. Sev-
eral variations of this method have been described 
l12-14J. These reports would seem to indicate 
widespread application of this procedure by phar-
maceutical laboratories. In our experience, the re-
sponse to croton oil, applied topically or in granu-
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lorna pouch procedures, has been quite variable. 
This is perhaps not unexpected, since croton oil, a 
relatively crude mixture of many constituents, 
varies in its irritant properties in different batches 
and with aging. 
In this rt!pori WI:! shall present dala in raU; on 
inflammation induced by the topical application of 
cantharidin. The results obtained demonstrate 
that cantharidin produces an inflammation which 
is amenable to topical corticosteroid mitigation, 
and that the procedure employed may be a useful 
method for finding and evaluating topical anti-
inflammatory compounds. 
MATERIALS AND METHODS 
Charles River CD 21- to 22-day-old male rats, 50 to 60 
gm body weight. were given an intraperitoneal injec-
tion of 0.12 ml Chloropent (Fort Dodge Laboratories. 
Fort Dodge. Iowa 50501). Mter the animals were an-
esthetized. 0.1 ml of the irritant solution was applied 
topically to the outer surface of one ear with a 0.5-mJ 
hypodermic syringe fitted with a 1 ' '-long 22-guage 
needle. The use of anesthetized animals enabled the 
accurate application of the topical solutions, and pre-
vented the animals from rubbing off the material prior 
to drying. The rats remained anesthetized for approxi-
mately 3 hr. A standardized vehicle was employed for 
all experiments and consisted of a mixture of 1 part 
ethanol. 1.5 parts collodion (USP), 2 parts acetone, and 
3 parts anhydrous diethyl ether by volume. Canthari-
din BP 1949 (J . H . Walker and Co., 22 W. First St., 
Mount Vernon. N.Y. 10550) alone or together with test 
compound was dissolved in this vehicle. Separate ag-
gregates or rats were employed as vehicle controls, 
cantharidin-alone group, and c8Jltharidin plus test 
compound group(s), and only one ear per rat was em-
ployed. 
In al1 experiments, except the time course study (see 
Fig. 2), animals were autopsied 72 hr after topical ap-
plication of cantharidin solutions. The rats were killed 
in C01 chambers and positioned so that the treated ears 
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were lying flat on a cork board covered with Parafilm M 
(American Can Co., New York, N.Y.). Samples of each 
treated ear were obtained by punching out a uniform 
disc with a #3 cork borer (9/a2" diameter) and weighing 
each tissue sample to the nearest 0.1 mg. Means, stan-
dard errors. and statistical significance by Student's t-
test were computed in the usual manner. 
RESULTS AND DISCUSSION 
The effect of the dose of topically applied can-
tharidin on ear punch weight measured 72 hr after 
application is shown in Figure 1. Topical doses of 
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FIG . 1. Effect of cantharidin dose on rat ear punch 
weight at 72 hr. Nine to 10 rats per group. Vertical lines 
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FIG. 2. Time-course of topical inflammation by 400 p..g 
of cantharidin. Each point represents the mean of 10 
rats. Range of standard errors: vehicle controls (lower 
curve ) 0.1- 0.3, cantharidin-treated ( upper curue) 0.3-
1.9. Differences between means at all time points sig-
nificant at p < 0.001. 
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cantly above vehicle-treated controls. The re-
sponse appeared to follow a linear log-dose rela-
tionship, and apparently attained the maximal 
response level with a dose at or near the 400-p.g 
level, since doses of 800 or 1000 p.g failed to cause 
further increments in response. The response to 
400 p.g of cantharidin was very consistent. In a 
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FIG. 3. Effect of administration route on activity of 
dexamethasone. a : Ear punch weight. All rats treated 
topically with 400 p..g cantharidin with autopsy at 72 hr . 
Irritant-alone group had 20 rats . All other groups had 7 
to 10 rats. Only topical dexamethasone groups signifi -
cantly different (p < 0.01 ) from canthandin-alone 
group. Oral and subcutaneous vehicle was 10%- ethanol/ 
90'*: sesame oi l by volume. b: Thymus weight. Same 
rats as in Fig. 3a. All mean thymus weight differences 
from cantharid in-alone group significant (p < 0.01) ex-
cept dexamethasone (subcutaneous) at 25 J.Lg dose, and 
dexamethasone (oral) at 25 and 50 ,.,.g doses. 
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TABLE. Effects of various corticosteroids and some nonsteroid compounds on topical inflammation induced with 
cantharidin 
All rats had 400 1-1-g of cantharidin applied topically 72 hr before autopsy. Each group bad 10 rats unless indicated 
other wise by value in parenthesis. Differences between - Compound and + Compound groups not significant 
statistically for any nonsteroid compound. Percent inhibition based on increase from vehicle controls. 
Compound Topical dose 
Mean ear punch weight lmg) :=: SE Significance of Percent in-
( !kg) 
- Compound + Compound difference hibition 
Hydrocortisone 320 28.2 ± 0.9 (20) 20.1 :!: 0. 7 (19) p < 0.001 52 
Prednisolone 80 23.3 ± 0.7 19.2 ± 1.3 (9) p < 0.001 35 
Triamcinolone 100 26.8 ± 0.8 (19) 22.2 ± 0.8 (19) p < 0.001 31 
Betamethasone 40 20.4 ::!: 0.6 (12) 17.4 ± 1.0 (9} p < 0.05 32 
Dexamethasone 40 19.9 ± 1.0 14.6 ± 1.1 p < 0.01 53 
Flurometholone 50 21.1 ± 1.5 (17) 17.0 ± 0.9 (17) p < 0.05 40 
Pa ramethasone acetate 100 21.1 ::!: 1.5 (17) 16.8 ± 0.6 (17) p < 0.05 41 
Fluocinolone acetonide 20 21.0 ± 1.2 (12) 14.3 ± 0.4 (12) p < 0.001 67 
Fluocinonide 10 24..5 ± 1.9 (9) 17.7 ~ 1.2 p < 0.01 53 
Flurandrenolide 40 20.4 ± 1.3 (12) 15.7 ± 1.3 (12) p < 0.05 52 
Diphenhydramine" 1000 20.0 ::: 1.3 
Tripelennamine 8000 20.9 :':: 1.0 
Chlorpheniramine1' 1000 18.8 ± 0.6 
Promethazine" 1500 22.6 ± 0. 7 
Cyroheptadine" 1000 21.1 ::: 0.5 
L-Epinephrine 4 18.8 :!: 0.6 
L-Phenylephrine" 250 22.6:'::0.7 
DL-a-Tocopherol 8000 23.1::: 1.2 
Indomethacin 1600 17.2 ::!: 1.1 
Bufexamac 1200 20.9 :':: 1.5 
" Hydrochlor ide 
b Maleate 
ing a 1-year interval , the increase in ear punch 
weight above controls varied from 79 to 106% with 
an average increase of 88%-. These data demon-
strate that t he inflammatory response to topically 
applied cantharidin, as measured by difference 
from control in tissue sample weigh t, is highly 
reproducible and consistent quantitatively. 
The course of topical inflammation induced with 
cantharidin is shown in Figure 2. Inflammation 
was clearly evident 1 day after topical application 
of 400 f..l.g of cantharidin, and attained its maximal 
degree at 7 days. The induced inflammation, as 
measured by tissue weight changes, subsided after 
7 days, but ear punch weights were still not at 
control levels at 10 days. 
It was considered of interest to determine 
whether an inactive steroid would mitigate can-
tharidin inflammation. Tests with cholesterol 
showed that it was ineffective in suppression of 
cantharidin inflammation at concentrations up to 
10%. Since most topically effective corticosteroids 
are active at concentrations considerably less than 
1%, the ability to inhibit cantharidin inflamma-
tion at reasonable dosages would easily distin-
guish active from inactive steroids. Indeed. as 
shown in Figure 3a, dexamethasone was effective 
topically at ·a concentration of 0.025% or less. 
It was of interest to detennine whether inhibi-
tion of cantharidin-induced inflammation by topi-
cally applied corticosteroids was due to systemic 
absorption or direct effect at the site of application. 
Figures 3a and b show the results obtained on ear 
18.5 ± 0.8 
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19.5 ± 1.1 
21.7 ± 1.2 
22.6 ::: 1.4 
17.9 ~ 1.2 
21.8 = 1.7 
22.7 ± 1.1 
18.9 ± 1.2 
18.8 ::':: 1.0 
punch weights and thymus gland weights after 
topical , subcutaneous, and oral administration of 
dexamethasone. Since thymus involution occurred 
after topical application of dexamethasone, it is 
evident that systemic absorption occurred. How-
ever, although subcutaneous and oral doses of the 
steroid caused equal thymus effect, only topically 
applied dexamethasone showed significant reduc-
tion in ear punch weights. These data demonstrate 
that the anti-inflammatory activity resulted from 
direct effect on the skin. 
In the Table are presented typical responses 
obtained in this test procedure with various corti-
costeroids. Although only single dose-response 
data are reported for each compound, t he degree of 
response at the dose employed gives some indica-
tion of relative effectiveness. In general, relative 
activity appeared to correlate with clinical effec-
tiveness. In other studies, we have obtained linear 
log- dose response curves for every topically active 
corticosteroid that has been examined by this pro-
cedure. 
In the Table data are also presented on some 
nonsteroidal compounds which have been tested 
for topical activity against cantha ridin-induced in-
flammation. Several antihistamines (diphenhy-
dramine, tripelennamine, chlorpheniramine, pro-
methazine), a serotonin and histamine antagonist 
(cyproheptadine), and two vasoconstrictors (epi-
nephrine, phenylephrine) were without effect at 
the dosages tested. Vitamin E has been reported to 
have both systemic and topical anti-inflammatory 
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activity [15]. As shown in t he Table, DL-a-tocoph-
erol was ineffective in suppression of cantharidin-
induced inflammation when applied topically in 
an 8% solution. Indomethacin, which is active in 
croton oil-induced inflammation when applied top-
ically [14], was ineffective against cantharidin in-
flammation. Bufexamac has been reported to be 
effective topically in ultraviolet erythema and 
against carrageenin-induced cutaneous edema 
[16]. Against cantharidin inflammation, bufexa-
mac was inactive at a topical dose of 1.2 mg (1.2% 
solution). 
Since the characteristics of the inflammatory 
response to cantharidin, its possible mitigation by 
drugs, its reproducibility and statistical variation 
were unknown when these studies were initiated, 
it was considered desirable to include vehicle con-
trols in each experiment. This enabled monitoring 
of the consistency of the response to cantharidin 
from experiment to experiment. Rats were not 
housed in individual cages, but in treatment 
groups, consequently, the use of only one ear per 
animal prevented physical contact by drug-treated 
ears with ears treated with irritant alone. It is 
obvious that the procedure can be modified, and 
perhaps improved, by using both ears and allow-
ing each rat to serve as its own control. 
Selection of different observation times may also 
be indicated for compounds with different bioa-
vailability characteristics. It is possible that the 
nonsteroid compounds tested might have shown 
topical anti-inflammatory effects if observations 
had been made at other time points or with higher 
dosages. It should be noted, however, that all of 
the steroids tested showed significant inhibition of 
inflammation at 72 hr, and were effective at rela-
tively low doses. The 72-hr observation period was 
selected because it gave a significant degree of 
inflammation (approximately 90% above vehicle 
controls) from which to measure drug effects after 
only a single application of drug. Presumably, 
measurements at peak response (7 days) would 
require multiple drug applications, or high drug 
concentrations to give drug effects quantitatively 
equal to those obtainable at the 72-hr time period. 
From a practical standpoint, the use of minimal 
quantities of test compounds for screening or study 
is advantageous. especially with compounds that 
are difficult and/or expensive to synthesize. 
Cantharidin-induced inflammation appears to 
be a useful procedure for screening and evaluation 
of topically active, anti-inflammatory compounds. 
The procedure would seem to be especially useful 
for the assessment of the activities of topical corti-
costeroids. The data obtained with nonsteroids 
would suggest that its value for testing such 
weaker compounds may be somewhat less, since 
indomethacin and bufexamac, agents active topi-
cally in other test procedures, were ineffective 
against cantharidin-induced inflammation. How-
Vol. 68, No.3 
ever, the limited experience with nonsteroids, and 
the relative paucity of topically effective, nonste-
roidal, anti-inflammatory compounds currently 
available for testing, preclude a definitive judge-
ment in this regard. 
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